Department of Anesthesiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China (mainland).
Med Sci Monit. 2023 Jun 24;29:e940044. doi: 10.12659/MSM.940044.
BACKGROUND Edentulous elderly patients often face challenges in airway management and are susceptible to hypoxemia. Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) provides high-flow nasal oxygenation, potentially extending safe apneic time (SAT). This study compared the efficacy of THRIVE versus facemask ventilation in improving oxygenation and extending SAT in edentulous elderly patients. MATERIAL AND METHODS Patients with more than 10 missing teeth and who were over 65 years old were randomly assigned to the facemask group (Group M, n=25) or the THRIVE group (Group T, n=25). Patients in Group M were pre-oxygenated with a facemask (6 L/min, FiO₂ 100%), while patients in Group T were pre-oxygenated with their mouths closed via THRIVE (30 L/min, FiO₂ 100%). After anesthesia induction, patients in Group M were ventilated with pressure-controlled ventilation. In Group T, the patient's mouth was kept closed, and the flow rate was adjusted to 70 L/min. Four min after cisatracurium administration, ventilation was stopped in Group M while Group T continued to receive oxygen (70 L/min, FiO₂ 100%).The primary outcome was SAT, which was attained at 4 min after injection of cisatracurium and ended when SpO₂ decreased to 95% or when apneic time reached 480 s. A secondary outcome was the reoxygenation time, defined as the time from the beginning of mechanical ventilation to the time when SpO₂ 98% was reached. RESULTS An SAT of 480 s was reached by all patients in Group T, but by only 6 patients in Group M (P<0.05). Compared with Group M, the reoxygenation time in Group T was significantly shorter (P<0.05). CONCLUSIONS As compared to facemask, THRIVE can extend the SAT, improve oxygenation, and reduce reoxygenation time.
无牙的老年患者在气道管理方面常常面临挑战,并且容易发生低氧血症。经鼻高流量湿化氧疗(THRIVE)提供高流量鼻氧疗,可能会延长安全无通气时间(SAT)。本研究比较了 THRIVE 与面罩通气在改善无牙老年患者氧合和延长 SAT 方面的效果。
选择有 10 颗以上缺失牙齿且年龄超过 65 岁的患者,随机分为面罩组(M 组,n=25)或 THRIVE 组(T 组,n=25)。M 组患者通过面罩预充氧(6 L/min,FiO₂100%),T 组患者闭口经 THRIVE 预充氧(30 L/min,FiO₂100%)。麻醉诱导后,M 组患者行压力控制通气,T 组患者保持口腔闭合,将气流速度调节至 70 L/min。顺式阿曲库铵给药 4 min 后,M 组停止通气,而 T 组继续吸氧(70 L/min,FiO₂100%)。主要结局指标为 SAT,即在顺式阿曲库铵注射后 4 min 达到,并在 SpO₂降至 95%或无通气时间达到 480 s 时结束。次要结局指标为再氧合时间,定义为开始机械通气至 SpO₂达到 98%的时间。
T 组所有患者的 SAT 均达到 480 s,而 M 组仅 6 例患者达到(P<0.05)。与 M 组相比,T 组的再氧合时间明显更短(P<0.05)。
与面罩相比,THRIVE 可以延长 SAT、改善氧合并减少再氧合时间。